AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INDINAVIR
8 registrations across 3 African markets— 6 active
Markets with INDINAVIR
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| INDIVIR-400 400 CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2015 |
| INDIVIR-400 400MG CAPSULE CAPSULE | 🇲🇼Malawi | — | expired | Jun 2012 |
| AVIRODIN gélule / 400 mg | 🇸🇳Senegal | RANBAXY LABORATOIRES LIMITED | active | — |
| CRIXIVAN GELULE | 🇲🇦Morocco | — | active | — |
| INDIVAN comprimé / 400 mg | 🇸🇳Senegal | CIPLA LTD | active | — |
| AVIRODIN GELULE | 🇲🇦Morocco | — | active | — |
| AVIRODIN GELULE | 🇲🇦Morocco | — | active | — |
| CRIXIVAN gélule / 400 mg | 🇸🇳Senegal | MERCK SHARP ET DOHME-CHIBRET | active | — |
INDINAVIR in Africa — Regulatory Overview
INDINAVIR is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Senegal, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 6 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.